The Pharmagellan guide to biotech forecasting and valuation:
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
[United States]
Pharmagellan
[2016]
|
| Ausgabe: | First edition |
| Schlagworte: | |
| Beschreibung: | xi, 124 Seiten Illustrationen |
| ISBN: | 9780998407500 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV048569573 | ||
| 003 | DE-604 | ||
| 005 | 20230110 | ||
| 007 | t | ||
| 008 | 221121s2016 xxua||| b||| 00||| eng d | ||
| 020 | |a 9780998407500 |9 978-0-9984075-0-0 | ||
| 035 | |a (OCoLC)1356734244 | ||
| 035 | |a (DE-599)BVBBV048569573 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-19 |a DE-M49 |a DE-188 | ||
| 084 | |a VX 5000 |0 (DE-625)147793: |0 (DE-603)412690764 |2 rvk | ||
| 084 | |a WIR 540 |2 stub | ||
| 084 | |a WIR 930 |2 stub | ||
| 084 | |a CIT 900 |2 stub | ||
| 100 | 1 | |a David, Frank S. |e Verfasser |0 (DE-588)1274860857 |4 aut | |
| 245 | 1 | 0 | |a The Pharmagellan guide to biotech forecasting and valuation |c Frank S. David, Seth Robey, Andrew Matthews |
| 246 | 1 | 3 | |a Biotech forecasting & valuation |
| 246 | 1 | 0 | |a Biotech forecasting and valuation |
| 250 | |a First edition | ||
| 264 | 1 | |a [United States] |b Pharmagellan |c [2016] | |
| 300 | |a xi, 124 Seiten |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 653 | 0 | |a Biotechnology / Economic aspects | |
| 653 | 0 | |a Biotechnologie / Aspect économique | |
| 653 | 0 | |a Biotechnology / Economic aspects | |
| 700 | 1 | |a Robey, Seth |e Verfasser |4 aut | |
| 700 | 1 | |a Matthews, Andrew |e Verfasser |4 aut | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-033945640 | ||
Datensatz im Suchindex
| _version_ | 1804184585282519040 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | David, Frank S. Robey, Seth Matthews, Andrew |
| author_GND | (DE-588)1274860857 |
| author_facet | David, Frank S. Robey, Seth Matthews, Andrew |
| author_role | aut aut aut |
| author_sort | David, Frank S. |
| author_variant | f s d fs fsd s r sr a m am |
| building | Verbundindex |
| bvnumber | BV048569573 |
| classification_rvk | VX 5000 |
| classification_tum | WIR 540 WIR 930 CIT 900 |
| ctrlnum | (OCoLC)1356734244 (DE-599)BVBBV048569573 |
| discipline | Chemie / Pharmazie Chemie-Ingenieurwesen Biotechnologie Wirtschaftswissenschaften |
| discipline_str_mv | Chemie / Pharmazie Chemie-Ingenieurwesen Biotechnologie Wirtschaftswissenschaften |
| edition | First edition |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01366nam a2200409 c 4500</leader><controlfield tag="001">BV048569573</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20230110 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">221121s2016 xxua||| b||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780998407500</subfield><subfield code="9">978-0-9984075-0-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1356734244</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048569573</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-M49</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 5000</subfield><subfield code="0">(DE-625)147793:</subfield><subfield code="0">(DE-603)412690764</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WIR 540</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WIR 930</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CIT 900</subfield><subfield code="2">stub</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">David, Frank S.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1274860857</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The Pharmagellan guide to biotech forecasting and valuation</subfield><subfield code="c">Frank S. David, Seth Robey, Andrew Matthews</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Biotech forecasting & valuation</subfield></datafield><datafield tag="246" ind1="1" ind2="0"><subfield code="a">Biotech forecasting and valuation</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">First edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[United States]</subfield><subfield code="b">Pharmagellan</subfield><subfield code="c">[2016]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xi, 124 Seiten</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biotechnology / Economic aspects</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biotechnologie / Aspect économique</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biotechnology / Economic aspects</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Robey, Seth</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Matthews, Andrew</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033945640</subfield></datafield></record></collection> |
| id | DE-604.BV048569573 |
| illustrated | Illustrated |
| index_date | 2024-07-03T21:01:46Z |
| indexdate | 2024-07-10T09:41:41Z |
| institution | BVB |
| isbn | 9780998407500 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033945640 |
| oclc_num | 1356734244 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-M49 DE-BY-TUM DE-188 |
| owner_facet | DE-19 DE-BY-UBM DE-M49 DE-BY-TUM DE-188 |
| physical | xi, 124 Seiten Illustrationen |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | Pharmagellan |
| record_format | marc |
| spelling | David, Frank S. Verfasser (DE-588)1274860857 aut The Pharmagellan guide to biotech forecasting and valuation Frank S. David, Seth Robey, Andrew Matthews Biotech forecasting & valuation Biotech forecasting and valuation First edition [United States] Pharmagellan [2016] xi, 124 Seiten Illustrationen txt rdacontent n rdamedia nc rdacarrier Biotechnology / Economic aspects Biotechnologie / Aspect économique Robey, Seth Verfasser aut Matthews, Andrew Verfasser aut |
| spellingShingle | David, Frank S. Robey, Seth Matthews, Andrew The Pharmagellan guide to biotech forecasting and valuation |
| title | The Pharmagellan guide to biotech forecasting and valuation |
| title_alt | Biotech forecasting & valuation Biotech forecasting and valuation |
| title_auth | The Pharmagellan guide to biotech forecasting and valuation |
| title_exact_search | The Pharmagellan guide to biotech forecasting and valuation |
| title_exact_search_txtP | The Pharmagellan guide to biotech forecasting and valuation |
| title_full | The Pharmagellan guide to biotech forecasting and valuation Frank S. David, Seth Robey, Andrew Matthews |
| title_fullStr | The Pharmagellan guide to biotech forecasting and valuation Frank S. David, Seth Robey, Andrew Matthews |
| title_full_unstemmed | The Pharmagellan guide to biotech forecasting and valuation Frank S. David, Seth Robey, Andrew Matthews |
| title_short | The Pharmagellan guide to biotech forecasting and valuation |
| title_sort | the pharmagellan guide to biotech forecasting and valuation |
| work_keys_str_mv | AT davidfranks thepharmagellanguidetobiotechforecastingandvaluation AT robeyseth thepharmagellanguidetobiotechforecastingandvaluation AT matthewsandrew thepharmagellanguidetobiotechforecastingandvaluation AT davidfranks biotechforecastingvaluation AT robeyseth biotechforecastingvaluation AT matthewsandrew biotechforecastingvaluation AT davidfranks biotechforecastingandvaluation AT robeyseth biotechforecastingandvaluation AT matthewsandrew biotechforecastingandvaluation |